Announcements Trials
Browse Landscape

Status

Completed 5Unknown 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Thoracic 1Dermatologic 1Breast 1

Conditions

Melanoma 1Lung Neoplasms 1Chronic Disease 1COVID-19 1Breast Neoplasms 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × COVID-19 Vaccines × Clear all
NCT04821570 2023-04-04

CANINE

University of Kansas Medical Center

Unknown
500 enrolled
BreastDermatologicThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma

NCT05043246 2022-08-10

SIM-PBD

The Second Affiliated Hospital of Chongqing Medical University

Unknown
2,300 enrolled

COVID-19, Chronic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡